Most drug development (preclinical and clinical) in diseases with 10 million or more cases per year.

https://doi.org/10.1371/journal.pntd.0006695.g004
Open external identifier URL

figure

posted on 2018-08-09, 17:30 authored by Kirk W. Kerr, Thomas C. Henry, Kathleen L. Miller

<p>Most drug development (preclinical and clinical) in diseases with 10 million or more cases per year.</p>

History

Related Materials

1.
DOI - Is supplement to Is the priority review voucher program stimulating new drug development for tropical diseases?

Usage metrics

Categories

Keywords

drug development priority review voucher program disease priority review voucher program

Licence

Exports